Why Cycling Matters: Receptor Desensitization
Receptor desensitization is the biological mechanism by which a cell reduces its sensitivity to a chronically present signal. When a receptor is repeatedly stimulated by the same ligand over an extended period, the cell employs several adaptive strategies to reduce the magnitude of the downstream signaling response: receptor internalization (the receptor is pulled inside the cell and away from the membrane), receptor downregulation (the cell produces fewer new receptors), and post-receptor signaling attenuation (the intracellular cascade becomes less responsive to receptor activation).
For GH secretagogues, this plays out specifically at the pituitary somatotroph cells that respond to GHRH (targeted by CJC-1295) and at the ghrelin receptor (GHS-R1a) targeted by Ipamorelin. After approximately 12–14 weeks of daily stimulation, the pituitary's GH release response to the same dose begins to decline. Users who fail to cycle report that the sleep quality improvements, body composition changes, and general wellbeing effects that were prominent in weeks 2–8 gradually fade by weeks 14–18. This is not because the peptides have stopped working — it is because the receptor system has adapted.
The 4-week off period allows receptor density and sensitivity to recover. When the ligand is removed, the cell re-expresses surface receptors at normal density and the post-receptor signaling cascade returns to its baseline responsiveness. Users who return to GH secretagogues after a proper off period consistently report that the initial response — the vivid dream quality, the sleep depth improvement, the GH "flush" — returns at the same intensity as the beginning of the first cycle.
IGF-1 LR3 requires more aggressive cycling — 4 weeks on / 4 weeks off — because its modified structure extends the half-life from 15 minutes (native IGF-1) to approximately 20–30 hours, producing sustained IGF-1 receptor stimulation that leads to faster receptor downregulation than native hormone pulsatility would produce.
Topical peptides like GHK-Cu and SNAP-8 do not require cycling because their mechanisms do not involve systemic receptor saturation in the same way. GHK-Cu signals through local fibroblast receptors — even with continuous daily application, the receptor system does not exhibit the same downregulation seen with systemic pituitary peptides.
12-Month Compound Schedule Grid
Color-coded status for each compound across all 12 months. Green = on cycle. Grey = off period. Gold dot = continuous. 10d = 10-day Epithalon window.
Compound-Specific Cycling Rules
What to Do During Off Periods
The off period is not dead time — it is an active phase of the protocol with specific objectives. Use it strategically.
Off periods are the ideal time for comprehensive bloodwork. IGF-1, GH (AM fasted), glucose, HbA1c, lipid panel, thyroid panel, and a complete metabolic panel. Bloodwork during active cycling may show elevated IGF-1 from exogenous peptide use — off period values represent your true baseline.
GHK-Cu and SNAP-8 continue without interruption during injectable off periods. Topicals are not subject to receptor desensitization — they continue building collagen and reducing expression lines throughout the off window.
Use the off period to objectively assess the results from your completed cycle. Photograph in consistent lighting and position. Assess body composition changes. Document sleep quality changes. This data informs dosing decisions for the next cycle.
Results from the completed cycle continue to consolidate during the off period — particularly collagen remodeling, which matures over weeks after synthesis stops. Maintain training consistency and protein intake to preserve muscle tissue accreted during the on cycle.
The off period allows GHRH and ghrelin receptor density to recover. Do not shorten the off period based on "feeling good." The point is to restore the receptor sensitivity that makes the next cycle as effective as the first — not to feel effects from the current cycle.
Signs of Receptor Desensitization
If you notice these signals while on cycle with GH secretagogues, it indicates that receptor desensitization is occurring and an off period should begin promptly — even if you haven't completed the planned 12 weeks.
These signs do not indicate that the compound is ineffective or that your body has permanently adapted. They indicate that the 4-week receptor recovery window is needed. Treating these as signals to "push through" with dose increases typically worsens the desensitization rather than overcoming it.
Common Questions
Build Your 12-Month Protocol
A full year of strategic peptide cycling delivers compounding results that no single cycle can match. Plan the calendar, source research-grade compounds, and execute consistently.